Abstract
Over the last several years, liver transplantation has evolved to become a widely used treatment for hepatocellular carcinoma (HCC). The criteria used were developed in order to have acceptable outcomes for transplant with survival similar to other indications for transplant. These criteria are discussed in detail along with alternate options, including surgical resection and downstaging of HCC in cirrhotics. Technical considerations of liver transplantation must be considered, and living donor liver transplant is a possibility for treatment.
Similar content being viewed by others
References
Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW (2011) Major challenges limiting liver transplantation in the united states. Am J Transplant 11(9):1773–1784
Kim WR, Lake JR, Smith JM, et al. (2017) OPTN/SRTR 2015 annual data report: liver. Am J Transplant 17(Suppl 1):174–251
El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med. 365:1118–1127
Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022
Clavien P-A, Lesurtel M, Bossuyt PMM, et al. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13(1):e11–e22
Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30:61–74
American Liver Tumor Study Group (1998) A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigators Booklet and Protocol Richmond. Richmond: Va United Network for Organ Sharing
Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R (1989) The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209(1):88–98
Adham M, Oussoultzoglou E, Ducerf C, et al. (1998) Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics. Transplant Int 11:S197–S200
Mazzaferro V, Regalia E, Doci R, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699
Mazzaferro V, Bhoori S, Sposito C, et al. (2011) Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transplant 17(supplement 2):S44–S57
Hemming AW, Cattral MS, Reed AI, et al. (2001) Liver transplantation for hepatocellular carcinoma. Ann Surg 233(5):652–659
Leung JY, Zhu AX, Gordon FD, et al. (2004) Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transplant 10(11):1343–1354
Yao FY, Xiao L, Bass NM, et al. (2007) Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 7:2587–2596
Yao FY, Ferrell L, Bass NM, et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6):1394–1403
Bhardwaj N, Perera MTPR, Silva MA (2016) Current treatment approaches to HCC with a special consideration to transplantation. J Transplant 2016:7926264
Duffy JP, Vardanian A, Benjamin E, et al. (2007) Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246(3):502–509 (discussion 509–11)
Kamath PS, Wiesner RH, Malinchoc M, et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33(2):464–470
https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf
Sharma P, Balan V, Hernandez JL, et al. (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transplant 10(1):36–41
Sharma P, Harper AM, Hernandez JL, et al. (2006) Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 6(8):1957–1962
Levi DM, Tzakis AG, Martin P, et al. (2010) Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg 210(5):727–734
Dutkowski P, Linecker M, DeOliveira ML, Müllhaupt B, Clavien PA (2015) Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology 148:307–323
https://optn.transplant.hrsa.gov/news/revised-liver-policy-regarding-hcc-exception-scores/. Accessed 20 Feb 2017
Iwatsuki S, Starzl TE, Sheahan DG, et al. (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann. Surg. 214(3):221–228 (discussion 228–9)
Bigourdan J-M, Jaeck D, Meyer N, et al. (2003) Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transplant 9:513–520
Vitale A, Huo T, Cucchetti A, et al. (2015) Survival benefit of liver transplantation versus resection for hepatocellular carcinoma: impact of MELD score. Ann Surg Oncol 22:1901
Proneth A, Zeman F, Schlitt HJ, Schnitzbauer AA (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21(9):3096–3107
Adam R, Azoulay D, Castaing D, et al. (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238(4):508–519
Nathan H, Bridges JFP, Schulick RD, et al. (2011) Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 29(6):619–625
Kadry Z, Schaefer EW, Uemura T, et al. (2012) Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States. J Hepatol 56:618–625
Zaydfudim VM, Vachharajani N, Klintmalm GB, et al. (2016) Liver resection and transplantation for patients with hepatocellular carcinoma beyond Milan criteria. Ann Surg 264(4):650–658
Ravaioli M, Grazi GL, Piscaglia F, et al. (2008) Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 8(12):2547–2557
Yao FY, Kerlan RK, Hirose R, et al. (2008) Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 48(3):819–827
Chapman WC, Majella Doyle M MB, Stuart JE, et al. (2008) Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 248(4):617–624
WC Chapman, Sandra Garcia-Aroz, Neeta Vachharajani, Kathryn Fowler, Nael Saad, Yiing Lin, Jason Wellen, Benjamin Tan, Adeel S. Khan, Majella Doyle Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions. Journal of the American College of Surgeons. Available online 6 January 2017.
Lo C (2008) Downstaging of hepatocellular carcinoma before transplantation: an advance in therapy or just another selection criterion. Am J Transplant 8:2485–2486
Yao FY, Mehta N, Flemming J, et al. (2015) Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within milan criteria. Hepatology 61(6):1968–1977
Mangus RS, Fridell JA, Vianna RM, et al. (2008) Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma. Transplantation. 85(10):1496–1499
Lee L, Foley D (2016) Technical aspects of orthotopic liver transplantation for hepatocellular carcinoma. Surg Clin North Am 96(2):269–281
Bekker J, Ploem S, de Jong KP (2009) Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 9:746–757
Panaro F, Ramos J, Gallix B, et al. (2014) Hepatic artery complications following liver transplantation. Does preoperative chemoembolization impact the postoperative course? Clin Transplant 28:598–605
Goel A, Mehta N, Guy J, et al. (2014) Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transplant 20(10):1221–1228
Richard HM III, Silberzweig JE, Mitty HA, et al. (2000) Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology 214:775–779
Wang P, Pu Y, Li H, et al. (2016) Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study. SpringerPlus 5(1):1809
Dai WC, Chan SC, Chok KSH, et al. (2014) Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter. HPB 16(8):749–757
Grant D, Fisher RA, Abecassis M, et al. (2011) Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation? Liver Transplant 17:S133–S138
Marsh JW, Gray E, Ness R, Starzl TE (2009) Complications of right lobe living donor liver transplantation. J Hepatol 51(4):715–724
Freise CE, Gillespie BW, Koffron AJ, et al. (2008) Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 8(12):2569–2579
Ratner LE, Sandoval PR (2010) When disaster strikes: death of a living organ donor. Am J Transplant 10(12):2577–2581
Lauterio A, Di Sandro S, Gruttadauria S, et al. (2016) Donor safety in living donor liver donation: an Italian multicenter survey. Liver Transplant 23:184–193
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berumen, J., Hemming, A. Liver transplantation for hepatocellular carcinoma. Abdom Radiol 43, 185–192 (2018). https://doi.org/10.1007/s00261-017-1217-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1217-1